KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2025)

Acadia Pharmaceuticals (ACAD) has 6 years of Inventory Average data on record, last reported at $66.7 million in Q2 2024.

  • For Q2 2024, Inventory Average changed N/A year-over-year to $66.7 million; the TTM value through Jun 2024 reached $66.7 million, changed N/A, while the annual FY2023 figure was $21.2 million, 192.45% up from the prior year.
  • Inventory Average reached $66.7 million in Q2 2024 per ACAD's latest filing, up from $48.9 million in the prior quarter.
  • Across five years, Inventory Average topped out at $66.7 million in Q2 2024 and bottomed at $6.1 million in Q3 2022.
  • Average Inventory Average over 4 years is $22.2 million, with a median of $10.0 million recorded in 2021.
  • Peak YoY movement for Inventory Average: plummeted 43.83% in 2022, then surged 667.85% in 2024.
  • A 4-year view of Inventory Average shows it stood at $11.1 million in 2021, then tumbled by 43.83% to $6.2 million in 2022, then rose by 2.01% to $6.4 million in 2023, then soared by 948.32% to $66.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $66.7 million in Q2 2024, $48.9 million in Q1 2024, and $6.4 million in Q1 2023.